News
-
-
-
-
-
PRESS RELEASE
Sartorius Stedim Biotech SA: Sartorius Stedim Biotech adjusts its guidance for fiscal year 2024 and presents results for H1 2024
Sartorius Stedim Biotech adjusts fiscal year 2024 guidance with positive sales trend in H1 2024 amid volatile market. Company's key financials and outlook disclosed -
-
-
-
PRESS RELEASE
Sartorius Stedim Biotech SA: Half-year liquidity contract statement for Sartorius Stedim Biotech
Sartorius Stedim Biotech's half-year liquidity contract statement reveals significant shares and volume on June 30th, 2024. The company is a key player in the biopharmaceutical industry with a global presence -